Compare Liquidia Corporation Common Stock (LQDA) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Under Armour Inc Class A — how do they compare? Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B), while Under Armour Inc Class A trades at $4.65 (market cap $2.03B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Liquidia Corporation Common Stock is more actively traded (21,111,778 versus 2,242,648). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Under Armour Inc Class A for 19 Days on average.
| LQDA | UA | |
|---|---|---|
Market Cap | $3.04B | $2.03B |
Volume | 21,111,778 | 2,242,648 |
Sector | Health | Consumer Cyclical |
52-Week High | $91.03 | $7.88 |
52-Week Low | $22.02 | $3.96 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $2.94B | $3.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Under Armour (UA) trades at $4.76, down 0.63% on the day, with a bullish technical signal but negative profitability. Recent earnings show mixed quarterly beats and misses, with Q1 2026 missing expectations. The company reported a net loss of -$201.27M for 2025, with revenue declining to $4.9B in 2026. Cash flow remains negative, and the stock faces headwinds from softer consumer demand.
The outlook is cautious due to persistent revenue declines and negative margins, though a low P/S ratio of 0.4 may attract value investors. Key risks include execution challenges and competitive pressure. Analyst sentiment is mixed, with 39.71% buy ratings but significant hold recommendations reflecting uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
